Elixiron Immunotherapeutics employs advances in translational medicine to identify targets from clinical observations, and various drug modalities including biologics from phage display and single human B cell cloning platforms, to develop innovative therapies for cancer and immunological diseases.
Read more â
Tired of ads? Enjoy an ad-free experience by signing up.
Unlock unlimited company data
Already a subscriber? Log in.
Our subscriber community includes professionals from these companies:
Similar companies
Tired of ads? Enjoy an ad-free experience by signing up.